Target intelligence / Profile preview

Neuroblastoma breakpoint family member 10 (NBPF10)

Target
NBPF10
Molecular classification
Other
01

Overview

Neuroblastoma breakpoint family member 10 (NBPF10) is a protein encoded by the NBPF10 gene in humans and is part of the neuroblastoma breakpoint family (NBPF), comprising many recently expanded, primate-specific genes primarily located in segmental duplications on chromosome 1q21.1[1][2][3][6]. NBPF10 contains repeated DUF1220 (also known as Olduvai) protein domains, a hallmark of this gene family, which are thought to play roles in brain evolution and have been linked to the severity of neurodevelopmental conditions[2][3][4]. NBPF10 has very low threonine content and may be less susceptible to post-translational modifications[1]. Although its function is not well characterized, altered expression or copy number variations of NBPF family genes are associated with a spectrum of developmental and neuropsychiatric diseases, congenital anomalies, and cancer, but there is no evidence NBPF10 acts as a receptor, enzyme, transporter, or as a direct drug target[1][2][3]. NBPF10 may have biomarker potential in odontoblasts, but no defined role as a therapeutic target has been documented[1]. There are no currently known interacting drugs, mechanisms of action, or safety concerns related to NBPF10 specifically.

Other names
AB6AG1NBPF9NBPF family member NBPF10neuroblastoma breakpoint family member 10NBPFA_HUMAN
02

Mechanism of action

Not applicable (no known therapeutic targeting)

03

Biological functions

Unknownpossible biomarker for odontoblast phenotype
04

Disease associations

Cancer (notably neuroblastoma, Fallopian tube carcinosarcoma)Developmental disorders1q21.1 deletion syndrome1q21.1 duplication syndromeMicrocephaly, macrocephalyAutismSchizophreniaCongenital heart diseaseIntellectual disabilityCongenital kidney and urinary tract anomalies
05

Biomarkers

Proposed as biomarker for odontoblast phenotype

Beyond the preview

Go deeper on Neuroblastoma breakpoint family member 10 (NBPF10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuroblastoma breakpoint family member 10 (NBPF10).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call